These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26856111)

  • 1. [Not Available].
    Duh D; Van Broeck D
    J Pharm Belg; 2015 Dec; (4):37-8. PubMed ID: 26856111
    [No Abstract]   [Full Text] [Related]  

  • 2. Switching from methadone to tapentadol for cancer pain.
    Mercadante S; Ferrera P; Adile C
    J Pain Symptom Manage; 2012 Sep; 44(3):e3-5. PubMed ID: 22819437
    [No Abstract]   [Full Text] [Related]  

  • 3. Perioperative considerations for "new" kids on the opioid block.
    Moyo J; Rashiq S
    Can J Anaesth; 2011 May; 58(5):417-9, 419-22. PubMed ID: 21350889
    [No Abstract]   [Full Text] [Related]  

  • 4. [The goal is: fewer side effects, better compliance (interview by Wolfgang van den Bergh, Michael Hubert and Helmut Laschet)].
    Martens K
    MMW Fortschr Med; 2011 Sep; 153(36):10. PubMed ID: 21936091
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dual mechanism of action of tapentadol].
    MMW Fortschr Med; 2012 Jun; 154(12):70-1. PubMed ID: 22880304
    [No Abstract]   [Full Text] [Related]  

  • 6. Tapentadol--the evidence so far.
    Ramaswamy S; Chang S; Mehta V
    Anaesthesia; 2015 May; 70(5):518-22. PubMed ID: 25866038
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating postoperative pain in the patient who is in recovery or remission from opioid abuse: Focus on Tapentadol.
    Barkin RL; Barkin SJ
    J Opioid Manag; 2017; 13(3):133-134. PubMed ID: 29441514
    [No Abstract]   [Full Text] [Related]  

  • 8. Strong analgesics: working towards an optimal balance between efficacy and side effects.
    Varrassi G; Marinangeli F; Piroli A; Coaccioli S; Paladini A
    Eur J Pain; 2010 Apr; 14(4):340-2. PubMed ID: 20219399
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain.
    Kwong WJ; Ozer-Stillman I; Miller JD; Haber NA; Russell MW; Kavanagh S
    Clin Ther; 2010 Sep; 32(10):1768-81. PubMed ID: 21194601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
    Candiotti KA; Gitlin MC
    Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tapentadol. Opioid analgesic and norepinephrine reuptake inhibitors].
    Weichel C; Hecht B
    Med Monatsschr Pharm; 2010 Dec; 33(12):454-60. PubMed ID: 21189520
    [No Abstract]   [Full Text] [Related]  

  • 12. Tapentadol (Palexia) for moderate to severe acute pain.
    Drug Ther Bull; 2012 Mar; 50(3):30-3. PubMed ID: 22419754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tapentadol for multimodal pain management.
    Pasero C
    J Perianesth Nurs; 2011 Oct; 26(5):343-6. PubMed ID: 21939888
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic update: tapentadol hydrochloride.
    Hersh EV; Golubic S; Moore PA
    Compend Contin Educ Dent; 2010 Oct; 31(8):594-9; quiz 600, 603. PubMed ID: 20960989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs: tapentadol hydrochloride, tolvaptan, and benzyl alcohol.
    Hussar DA
    J Am Pharm Assoc (2003); 2009; 49(5):704-8. PubMed ID: 19748880
    [No Abstract]   [Full Text] [Related]  

  • 18. Should opioid analgesics be used in the management of chronic pain in opiate addicts?
    Collins ED; Streltzer J
    Am J Addict; 2003; 12(2):93-100. PubMed ID: 12746085
    [No Abstract]   [Full Text] [Related]  

  • 19. Avoiding Problems from Opioid Pain Medicine.
    Am Fam Physician; 2016 Jun; 93(12):Online. PubMed ID: 27304780
    [No Abstract]   [Full Text] [Related]  

  • 20. Tapentadol (Nucynta)--a new analgesic.
    Med Lett Drugs Ther; 2009 Aug; 51(1318):61-2. PubMed ID: 19661853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.